Venetoclax plus modified intensive chemotherapy (CAVEAT) is well tolerated and effective (75% remission) in fit, older patients with AML. https://buff.ly/yYKRjn5 #hemesky #clinicaltrialsandobservations #myeloidneoplasia
Post image

Comments